Comparative Effectiveness of Prostate Cancer Surgical Treatments: A Population Based Analysis of Postoperative Outcomes
To access this article, please choose from the options below
Supported by National Institutes of Health 1RC1CA146516-01 (JAE, EBE, WTL, DSY), T32-CA82088 (PTS, WTL), National Cancer Institute P50-CA92629 SPORE (PTS) and CA118189-01A2 (EBE), Sidney Kimmel Center for Prostate and Urologic Cancers, David H. Koch provided through the Prostate Cancer Foundation and Memorial Sloan-Kettering Cancer Center.
Supplementary material for this article can be obtained at http://www.mskcc.org/comparative-effectiveness-prostate-cancer/journalofurology.
For other articles on a related topic see pages 1598 and 1619.
PII: S0022-5347(09)03185-1
doi:10.1016/j.juro.2009.12.021
© 2010 American Urological Association Education and Research, Inc. Published by Elsevier Inc All rights reserved.
Refers to article:
- Screening Agents for Preventive Efficacy in a Bladder Cancer Model: Study Design, End Points, and Gefitinib and Naproxen Efficacy , 22 February 2010
- Effect of Isocaloric Low Fat Diet on Prostate Cancer Xenograft Progression in a Hormone Deprivation Model , 22 February 2010
Refers to erratum:
- Errata , 23 June 2010

